Doximity, Inc.DOCSNYSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank33
3Y CAGR-31.6%
5Y CAGR-5.6%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-31.6%/yr
Annual compound
5Y CAGR
-5.6%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 13.48% |
| 2024 | 2.24% |
| 2023 | 28.61% |
| 2022 | 42.11% |
| 2021 | 35.26% |
| 2020 | 17.95% |
| 2019 | 0.00% |